Development of t(8;21) and RUNX1–RUNX1T1 in the Philadelphia-positive clone of a patient with chronic myelogenous leukemia: additional evidence for multiple steps involved in disease progression

Fialkow, 1977, Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage, Am J Med, 63, 125, 10.1016/0002-9343(77)90124-3 Fialkow, 1981, Evidence for a multistep pathogenesis of chronic myelogenous leukemia, Blood, 58, 158, 10.1182/blood.V58.1.158.158 Martin, 1982, B-lymphoid cell involvement in chronic myelogenous leukemia: implications for the pathogenesis of the disease, Cancer Genet Cytogenet, 6, 359, 10.1016/0165-4608(82)90092-9 Raskind, 1993, Further evidence for the existence of a clonal Ph-negative stage in some cases of Ph-positive chronic myelocytic leukemia, Leukemia, 7, 1163 Feldman, 2003, The emergence of Ph−, trisomy-8+ cells in patients with chronic myeloid leukemia treated with imatinib mesylate, Exp Hematol, 31, 702, 10.1016/S0301-472X(03)00176-0 Andersen, 2002, Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8, Leukemia, 16, 1390, 10.1038/sj.leu.2402634 Bumm, 2003, Emergence of clonal cytogenetic abnormalities in Ph− cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority, Blood, 101, 1941, 10.1182/blood-2002-07-2053 Francesconi, 1978, 8/21 Translocation, loss of the Y chromosome and Philadelphia chromosome, Br J Haematol, 38, 149, 10.1111/j.1365-2141.1978.tb07117.x Xue, 1991, A case of basophilic leukemia bearing simultaneous translocations t(8;21) and t(9;22), Cancer Genet Cytogenet, 51, 215, 10.1016/0165-4608(91)90134-G Ammatuna, 2009, Simultaneous occurrence of BCR/ABL1 and RUNX1/RUNX1T1 in a case of therapy-related acute myeloid leukemia, Cancer Genet Cytogenet, 195, 189, 10.1016/j.cancergencyto.2009.08.014 Ferro, 1992, Ph-positive chronic myeloid leukemia with t(8;21)(q22;q22) in blast crisis, Cancer Genet Cytogenet, 58, 96, 10.1016/0165-4608(92)90143-V Kojima, 1999, Additional translocation (8;21)(q22;q22) in a patient with Philadelphia-positive chronic myelogenous leukemia in the blast phase, Br J Haematol, 106, 720, 10.1046/j.1365-2141.1999.01588.x Yin, 2004, t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia, Am J Clin Pathol, 121, 836, 10.1309/H8JH6L094B9U3HGT Schafhausen, 2009, Development of AML with t(8;21)(q22;q22) and RUNX1–RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with imatinib, Cancer Genet Cytogenet, 189, 63, 10.1016/j.cancergencyto.2008.09.016 Arber DA, Beunning RD, Le Beau MM, et al. Acute myeloid leukemia with recurrent genetic abnormalities. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Geneva: World Health Organization; Lyon: IARC Press, 2008, pp. 110–122. Najfeld, 1998, Acquisition of the Ph chromosome and BCR–ABL fusion in AML-M2 and t(8;21) leukemia: cytogenetic and FISH evidence for a late event, Leukemia, 12, 517, 10.1038/sj.leu.2400974 Secker-Walker, 1992, Inversion of chromosome 16 with the Philadelphia chromosome in acute myelomonocytic leukemia with eosinophilia: report of two cases, Cancer Genet Cytogenet, 58, 29, 10.1016/0165-4608(92)90129-V Wu, 2006, Coexistence of inversion 16 and the Philadelphia chromosome in acute and chronic myeloid leukemia, Am J Clin Pathol, 125, 260, 10.1309/F0MX5CL8CEDY3W86 Miura, 1994, Standard Ph chromosome t(9;22)(q34;q11), as an additional change in a patient with acute myelomonocytic leukemia (M4Eo) associated with inv(16)(p13q22), Am J Hematol, 45, 94, 10.1002/ajh.2830450118